LETTER
New Catalyst Combination for Oxidation of Indoles
2027
(17) Palaniappan, S.; Lakshmi Devi, S. Polymer Degrad. Stabil.
2006, 91, 2415.
Acknowledgment
The authors thank Dr. J. S. Yadav, Director, Indian Institute of Che-
mical Technology, for facilities and encouragement. C.S.P. and
C.L.D thank the Council of Scientific and Industrial Research, New
Delhi for the research fellowship. The authors also thank Dr. S.
Raghavan, IICT for his helpful discussion.
(18) Representative Experimental Procedure: In a typical
experiment, PCC (2.5 mmol, 537 mg) was added to a
solution of indole (1 mmol, 117 mg) in 1,2-DCE (5 mL).
Polyaniline salt catalyst [15 wt% with respect to indole (17
mg)] was added and the reaction mixture was stirred at r.t. or
at reflux. Completion of the reaction was monitored by TLC.
After completion, the reaction mixture was filtered through
a Celite® pad and washed with EtOAc (2 × 5 mL). The
combined organic extracts were dried and evaporated under
vacuum. The crude product was purified by silica gel
column chromatography (n-hexane–EtOAc, 3:1) to furnish
isatin (129 mg, 88%). A similar procedure was adopted for
the preparation of other isatins, 3-hydroxy oxindoles and the
authenticity of the products was confirmed from their 1H
NMR and mass spectral data.
References and Notes
(1) Vine, K. L.; Locke, J. M.; Ranson, M.; Pyne, S. G.; Bremner,
J. B. J. Med. Chem. 2007, 50, 5109.
(2) (a) Verma, M.; Pandeya, S. N.; Singh, K. N.; Stables, J. P.
Acta Pharm. 2004, 54, 49. (b) Bhattacharya, S. K.;
Chakrabarti, A. Ind. J. Exp. Biol. 1998, 36, 118.
(c) Pajouhesh, H.; Parson, R.; Popp, F. D. J. Pharm. Sci.
1983, 72, 318.
(3) Kitaura, Y.; Ito, F.; Stevens, R. W.; Asai, N. US Patent, US
4835166, 1989; Chem. Abstr. 1989, 112, 35864t.
(4) (a) Varma, R. S.; Nobles, W. L. J. Pharm. Sci. 1975, 64,
881. (b) Gil-Turnes, M. S.; Hay, M. E.; Fenical, W. Science
1989, 246, 116. (c) Fatima, I.; Ahmad, I.; Anis, I.; Malik, A.;
Afza, N. Molecules 2007, 12, 155.
(5) (a) Maysinger, D.; Movrin, M. Arzneim.-Forsch. 1980, 30,
1839. (b) Movrin, M.; Medić-Sarić, M. Eur. J. Med. Chem.
1978, 13, 309.
(19) Spectral Data for New Compounds:
1-Butyl-5-chloroindoline-2,3-dione (Table 2, entry 8):
TLC: Rf 0.5 (30% EtOAc–hexanes); orange solid; mp 62–63
°C. IR (KBr): 3089, 2953, 1737, 1606, 1448, 1339, 1185,
1116, 844, 720 cm–1. 1H NMR (200 MHz, CDCl3): d = 7.49
(m, J = 8.1 Hz, 2 H), 6.80 (d, J = 8.1 Hz, 1 H), 3.70 (t, J =
7.3 Hz, 2 H), 1.67 (quint, J = 7.3 Hz, 2 H), 1.43 (m, J = 7.3
Hz, 2 H), 0.98 (t, J = 7.3 Hz, 3 H). 13C NMR (200 MHz,
CDCl3): d = 182.5, 157.6, 149.4, 137.5, 129.3, 125.1, 118.3,
111.8, 40.07, 29.08, 20.0, 13.5. MS (ESI): m/z = 238 [M +
H+]. HRMS (ESI): m/z [M + H+] calcd for C12H13NClO2:
238.0634; found 238.0630.
(6) Da Silva, J. F. M.; Garden, S. J.; Pinto, A. C. J. Braz. Chem.
Soc. 2001, 12, 273.
(7) Sassatelli, M.; Debiton, E.; Aboab, B.; Prudhomme, M.;
1-Methyl-5-nitroindoline-2,3-dione (Table 2, entry 9):
TLC: Rf 0.3 (50% EtOAc–hexanes); yellowish orange solid;
mp 203 °C. IR (KBr): 2924, 1743, 1610, 1465, 1331, 1289,
1109, 1074, 845, 747, 710, 600 cm–1. 1H NMR (200 MHz,
CDCl3): d = 8.47 (dd, J = 8.8 Hz, 1 H), 8.34 (d, 1 H), 7.06 (d,
J = 8.8 Hz, 1 H), 3.29 (s, 3 H). 13C NMR (200 MHz, CDCl3):
d = 182.1, 157.3, 150.3, 140.5, 128.0, 118.3, 116.7, 111.5,
26.2. GC–MS: m/z = 206 [M+]. Anal. Calcd for C9H6N2O4:
C, 52.44; H, 2.93; N, 13.59. Found: C, 52.40; H, 2.78; N,
13.42.
Moreau, P. Eur. J. Med Chem. 2006, 41, 709.
(8) Kawasaki, T.; Nagaoka, M.; Satoh, T.; Okamoto, A.; Ukon,
T. R.; Ogawa, A. Tetrahedron 2004, 60, 3493.
(9) (a) Sandmeyer, T. Helv. Chim. Acta 1919, 2, 234.
(b) Marvel, C. S.; Hiers, G. S. Org. Synth. 1941, 1, 327.
(10) (a) Noland, W. E.; Rieke, R. D. J. Org. Chem. 1962, 27,
2250. (b) Sassatelli, M.; Saab, E.; Anizan, F.; Prudhomme,
M.; Moreau, P. Tetrahedron Lett. 2004, 45, 4827.
(11) Parrick, J.; Yahya, A.; Ijaz, A. S.; Yizun, J. J. Chem. Soc.,
Perkin Trans. 1 1989, 2009.
1-Octyl-1H-pyrrolo[2,3-b]pyridine-2,3-dione (Table 2,
entry 15): TLC: Rf 0.5 (30% EtOAc–hexanes); yellow solid;
mp 74–76 °C. IR (KBr): 3063, 2925, 2855, 1737, 1592,
1456, 1353, 1263, 1085, 783, 738 cm–1. 1H NMR (200 MHz,
CDCl3): d = 8.41 (d, 1 H), 7.78 (d, 1 H), 7.05 (t, 1 H), 3.83
(12) Tatsugi, J.; Zhiwei, T.; Izawa, Y. ARKIVOC 2001, (i), 67.
(13) Yadav, J. S.; Reddy, B. V. S.; Reddy, C. S.; Krishna, A. D.
Synthesis 2007, 693.
(14) Yadav, J. S.; Reddy, B. V. S.; Reddy, C. S.; Krishna, A. D.
Tetrahedron Lett. 2007, 48, 2029.
(t, 2 H), 1.74 (t, 2 H), 1.25–1.35 (m, 10 H), 0.87 (t, 3 H). 13
C
(15) Piancatelli, G.; Scettri, A.; D’Auria, M. Synthesis 1982, 245.
(16) (a) Srinivas, C.; Kumar, C. N. S. S. P.; Rao, V. J.;
Palaniappan, S. J. Mol. Catal. A: Chem. 2007, 265, 227.
(b) Srinivas, U.; Srinivas, C.; Narender, P.; Rao, V. J.;
Palaniappan, S. Catal. Commun. 2007, 8, 107.
NMR (200 MHz, CDCl3): d = 180.9, 163.3, 157.3, 154.9,
131.8, 118.1, 110.9, 38.9, 30.7, 28.6, 28.1, 26.5, 25.8, 21.6,
13.03. MS (ESI): m/z = 261 [M + H+]. HRMS (ESI): m/z [M
+ H+] calcd for C15H21N2O2: 261.1603; found: 261.1606.
Synlett 2008, No. 13, 2023–2027 © Thieme Stuttgart · New York